- IBDEI1TG ; ; 04-FEB-2020
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,29013,1,0)
- ;;=^358.31IA^3^2
- ;;^UTILITY(U,$J,358.3,29013,1,2,0)
- ;;=2^97533
- ;;^UTILITY(U,$J,358.3,29013,1,3,0)
- ;;=3^Sensory Integrative Techniques,per 15 min
- ;;^UTILITY(U,$J,358.3,29014,0)
- ;;=97537^^117^1451^1^^^^1
- ;;^UTILITY(U,$J,358.3,29014,1,0)
- ;;=^358.31IA^3^2
- ;;^UTILITY(U,$J,358.3,29014,1,2,0)
- ;;=2^97537
- ;;^UTILITY(U,$J,358.3,29014,1,3,0)
- ;;=3^Community/Work Reintegration,Ea 15 min
- ;;^UTILITY(U,$J,358.3,29015,0)
- ;;=97545^^117^1451^6^^^^1
- ;;^UTILITY(U,$J,358.3,29015,1,0)
- ;;=^358.31IA^3^2
- ;;^UTILITY(U,$J,358.3,29015,1,2,0)
- ;;=2^97545
- ;;^UTILITY(U,$J,358.3,29015,1,3,0)
- ;;=3^Work Hardening/Conditioning,Init 2 hrs
- ;;^UTILITY(U,$J,358.3,29016,0)
- ;;=97546^^117^1451^7^^^^1
- ;;^UTILITY(U,$J,358.3,29016,1,0)
- ;;=^358.31IA^3^2
- ;;^UTILITY(U,$J,358.3,29016,1,2,0)
- ;;=2^97546
- ;;^UTILITY(U,$J,358.3,29016,1,3,0)
- ;;=3^Work Hardening/Conditioning,Ea Addl Hr
- ;;^UTILITY(U,$J,358.3,29017,0)
- ;;=98961^^117^1451^3^^^^1
- ;;^UTILITY(U,$J,358.3,29017,1,0)
- ;;=^358.31IA^3^2
- ;;^UTILITY(U,$J,358.3,29017,1,2,0)
- ;;=2^98961
- ;;^UTILITY(U,$J,358.3,29017,1,3,0)
- ;;=3^Self-Mgmt Educ/Trng,2-4 Pts,Ea 30 min
- ;;^UTILITY(U,$J,358.3,29018,0)
- ;;=98962^^117^1451^4^^^^1
- ;;^UTILITY(U,$J,358.3,29018,1,0)
- ;;=^358.31IA^3^2
- ;;^UTILITY(U,$J,358.3,29018,1,2,0)
- ;;=2^98962
- ;;^UTILITY(U,$J,358.3,29018,1,3,0)
- ;;=3^Self-Mgmt Educ/Trng,5-8 Pts,Ea 30 min
- ;;^UTILITY(U,$J,358.3,29019,0)
- ;;=99078^^117^1451^2^^^^1
- ;;^UTILITY(U,$J,358.3,29019,1,0)
- ;;=^358.31IA^3^2
- ;;^UTILITY(U,$J,358.3,29019,1,2,0)
- ;;=2^99078
- ;;^UTILITY(U,$J,358.3,29019,1,3,0)
- ;;=3^Group Health Education/Counseling
- ;;^UTILITY(U,$J,358.3,29020,0)
- ;;=96372^^117^1452^1^^^^1
- ;;^UTILITY(U,$J,358.3,29020,1,0)
- ;;=^358.31IA^3^2
- ;;^UTILITY(U,$J,358.3,29020,1,2,0)
- ;;=2^96372
- ;;^UTILITY(U,$J,358.3,29020,1,3,0)
- ;;=3^Ther/Proph/Diag Inj SC/IM
- ;;^UTILITY(U,$J,358.3,29021,0)
- ;;=96402^^117^1452^2^^^^1
- ;;^UTILITY(U,$J,358.3,29021,1,0)
- ;;=^358.31IA^3^2
- ;;^UTILITY(U,$J,358.3,29021,1,2,0)
- ;;=2^96402
- ;;^UTILITY(U,$J,358.3,29021,1,3,0)
- ;;=3^Anti-Neoplastic,Hormonal,IM
- ;;^UTILITY(U,$J,358.3,29022,0)
- ;;=J1630^^117^1452^3^^^^1
- ;;^UTILITY(U,$J,358.3,29022,1,0)
- ;;=^358.31IA^3^2
- ;;^UTILITY(U,$J,358.3,29022,1,2,0)
- ;;=2^J1630
- ;;^UTILITY(U,$J,358.3,29022,1,3,0)
- ;;=3^Haloperidol,up to 5mg
- ;;^UTILITY(U,$J,358.3,29023,0)
- ;;=J1631^^117^1452^4^^^^1
- ;;^UTILITY(U,$J,358.3,29023,1,0)
- ;;=^358.31IA^3^2
- ;;^UTILITY(U,$J,358.3,29023,1,2,0)
- ;;=2^J1631
- ;;^UTILITY(U,$J,358.3,29023,1,3,0)
- ;;=3^Haloperidol Decanoate,per 50mg
- ;;^UTILITY(U,$J,358.3,29024,0)
- ;;=J2680^^117^1452^5^^^^1
- ;;^UTILITY(U,$J,358.3,29024,1,0)
- ;;=^358.31IA^3^2
- ;;^UTILITY(U,$J,358.3,29024,1,2,0)
- ;;=2^J2680
- ;;^UTILITY(U,$J,358.3,29024,1,3,0)
- ;;=3^Fluphenazine Decanoate,up to 25mg
- ;;^UTILITY(U,$J,358.3,29025,0)
- ;;=J2794^^117^1452^6^^^^1
- ;;^UTILITY(U,$J,358.3,29025,1,0)
- ;;=^358.31IA^3^2
- ;;^UTILITY(U,$J,358.3,29025,1,2,0)
- ;;=2^J2794
- ;;^UTILITY(U,$J,358.3,29025,1,3,0)
- ;;=3^Risperidone,Long Acting,per 0.5mg
- ;;^UTILITY(U,$J,358.3,29026,0)
- ;;=90867^^117^1453^3^^^^1
- ;;^UTILITY(U,$J,358.3,29026,1,0)
- ;;=^358.31IA^3^2
- ;;^UTILITY(U,$J,358.3,29026,1,2,0)
- ;;=2^90867
- ;;^UTILITY(U,$J,358.3,29026,1,3,0)
- ;;=3^TMS,Initial
- ;;^UTILITY(U,$J,358.3,29027,0)
- ;;=90868^^117^1453^4^^^^1
- ;;^UTILITY(U,$J,358.3,29027,1,0)
- ;;=^358.31IA^3^2
- ;;^UTILITY(U,$J,358.3,29027,1,2,0)
- ;;=2^90868
- ;;^UTILITY(U,$J,358.3,29027,1,3,0)
- ;;=3^TMS,Subseq Delivery & Mgmt,per session
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1TG 3825 printed Feb 18, 2025@23:41:49 Page 2
- IBDEI1TG ; ; 04-FEB-2020
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,29013,1,0)
- +2 ;;=^358.31IA^3^2
- +3 ;;^UTILITY(U,$J,358.3,29013,1,2,0)
- +4 ;;=2^97533
- +5 ;;^UTILITY(U,$J,358.3,29013,1,3,0)
- +6 ;;=3^Sensory Integrative Techniques,per 15 min
- +7 ;;^UTILITY(U,$J,358.3,29014,0)
- +8 ;;=97537^^117^1451^1^^^^1
- +9 ;;^UTILITY(U,$J,358.3,29014,1,0)
- +10 ;;=^358.31IA^3^2
- +11 ;;^UTILITY(U,$J,358.3,29014,1,2,0)
- +12 ;;=2^97537
- +13 ;;^UTILITY(U,$J,358.3,29014,1,3,0)
- +14 ;;=3^Community/Work Reintegration,Ea 15 min
- +15 ;;^UTILITY(U,$J,358.3,29015,0)
- +16 ;;=97545^^117^1451^6^^^^1
- +17 ;;^UTILITY(U,$J,358.3,29015,1,0)
- +18 ;;=^358.31IA^3^2
- +19 ;;^UTILITY(U,$J,358.3,29015,1,2,0)
- +20 ;;=2^97545
- +21 ;;^UTILITY(U,$J,358.3,29015,1,3,0)
- +22 ;;=3^Work Hardening/Conditioning,Init 2 hrs
- +23 ;;^UTILITY(U,$J,358.3,29016,0)
- +24 ;;=97546^^117^1451^7^^^^1
- +25 ;;^UTILITY(U,$J,358.3,29016,1,0)
- +26 ;;=^358.31IA^3^2
- +27 ;;^UTILITY(U,$J,358.3,29016,1,2,0)
- +28 ;;=2^97546
- +29 ;;^UTILITY(U,$J,358.3,29016,1,3,0)
- +30 ;;=3^Work Hardening/Conditioning,Ea Addl Hr
- +31 ;;^UTILITY(U,$J,358.3,29017,0)
- +32 ;;=98961^^117^1451^3^^^^1
- +33 ;;^UTILITY(U,$J,358.3,29017,1,0)
- +34 ;;=^358.31IA^3^2
- +35 ;;^UTILITY(U,$J,358.3,29017,1,2,0)
- +36 ;;=2^98961
- +37 ;;^UTILITY(U,$J,358.3,29017,1,3,0)
- +38 ;;=3^Self-Mgmt Educ/Trng,2-4 Pts,Ea 30 min
- +39 ;;^UTILITY(U,$J,358.3,29018,0)
- +40 ;;=98962^^117^1451^4^^^^1
- +41 ;;^UTILITY(U,$J,358.3,29018,1,0)
- +42 ;;=^358.31IA^3^2
- +43 ;;^UTILITY(U,$J,358.3,29018,1,2,0)
- +44 ;;=2^98962
- +45 ;;^UTILITY(U,$J,358.3,29018,1,3,0)
- +46 ;;=3^Self-Mgmt Educ/Trng,5-8 Pts,Ea 30 min
- +47 ;;^UTILITY(U,$J,358.3,29019,0)
- +48 ;;=99078^^117^1451^2^^^^1
- +49 ;;^UTILITY(U,$J,358.3,29019,1,0)
- +50 ;;=^358.31IA^3^2
- +51 ;;^UTILITY(U,$J,358.3,29019,1,2,0)
- +52 ;;=2^99078
- +53 ;;^UTILITY(U,$J,358.3,29019,1,3,0)
- +54 ;;=3^Group Health Education/Counseling
- +55 ;;^UTILITY(U,$J,358.3,29020,0)
- +56 ;;=96372^^117^1452^1^^^^1
- +57 ;;^UTILITY(U,$J,358.3,29020,1,0)
- +58 ;;=^358.31IA^3^2
- +59 ;;^UTILITY(U,$J,358.3,29020,1,2,0)
- +60 ;;=2^96372
- +61 ;;^UTILITY(U,$J,358.3,29020,1,3,0)
- +62 ;;=3^Ther/Proph/Diag Inj SC/IM
- +63 ;;^UTILITY(U,$J,358.3,29021,0)
- +64 ;;=96402^^117^1452^2^^^^1
- +65 ;;^UTILITY(U,$J,358.3,29021,1,0)
- +66 ;;=^358.31IA^3^2
- +67 ;;^UTILITY(U,$J,358.3,29021,1,2,0)
- +68 ;;=2^96402
- +69 ;;^UTILITY(U,$J,358.3,29021,1,3,0)
- +70 ;;=3^Anti-Neoplastic,Hormonal,IM
- +71 ;;^UTILITY(U,$J,358.3,29022,0)
- +72 ;;=J1630^^117^1452^3^^^^1
- +73 ;;^UTILITY(U,$J,358.3,29022,1,0)
- +74 ;;=^358.31IA^3^2
- +75 ;;^UTILITY(U,$J,358.3,29022,1,2,0)
- +76 ;;=2^J1630
- +77 ;;^UTILITY(U,$J,358.3,29022,1,3,0)
- +78 ;;=3^Haloperidol,up to 5mg
- +79 ;;^UTILITY(U,$J,358.3,29023,0)
- +80 ;;=J1631^^117^1452^4^^^^1
- +81 ;;^UTILITY(U,$J,358.3,29023,1,0)
- +82 ;;=^358.31IA^3^2
- +83 ;;^UTILITY(U,$J,358.3,29023,1,2,0)
- +84 ;;=2^J1631
- +85 ;;^UTILITY(U,$J,358.3,29023,1,3,0)
- +86 ;;=3^Haloperidol Decanoate,per 50mg
- +87 ;;^UTILITY(U,$J,358.3,29024,0)
- +88 ;;=J2680^^117^1452^5^^^^1
- +89 ;;^UTILITY(U,$J,358.3,29024,1,0)
- +90 ;;=^358.31IA^3^2
- +91 ;;^UTILITY(U,$J,358.3,29024,1,2,0)
- +92 ;;=2^J2680
- +93 ;;^UTILITY(U,$J,358.3,29024,1,3,0)
- +94 ;;=3^Fluphenazine Decanoate,up to 25mg
- +95 ;;^UTILITY(U,$J,358.3,29025,0)
- +96 ;;=J2794^^117^1452^6^^^^1
- +97 ;;^UTILITY(U,$J,358.3,29025,1,0)
- +98 ;;=^358.31IA^3^2
- +99 ;;^UTILITY(U,$J,358.3,29025,1,2,0)
- +100 ;;=2^J2794
- +101 ;;^UTILITY(U,$J,358.3,29025,1,3,0)
- +102 ;;=3^Risperidone,Long Acting,per 0.5mg
- +103 ;;^UTILITY(U,$J,358.3,29026,0)
- +104 ;;=90867^^117^1453^3^^^^1
- +105 ;;^UTILITY(U,$J,358.3,29026,1,0)
- +106 ;;=^358.31IA^3^2
- +107 ;;^UTILITY(U,$J,358.3,29026,1,2,0)
- +108 ;;=2^90867
- +109 ;;^UTILITY(U,$J,358.3,29026,1,3,0)
- +110 ;;=3^TMS,Initial
- +111 ;;^UTILITY(U,$J,358.3,29027,0)
- +112 ;;=90868^^117^1453^4^^^^1
- +113 ;;^UTILITY(U,$J,358.3,29027,1,0)
- +114 ;;=^358.31IA^3^2
- +115 ;;^UTILITY(U,$J,358.3,29027,1,2,0)
- +116 ;;=2^90868
- +117 ;;^UTILITY(U,$J,358.3,29027,1,3,0)
- +118 ;;=3^TMS,Subseq Delivery & Mgmt,per session
